The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Multifactorial analysis of p53 alteration in human cancer: A review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
A role for sunlight in skin-cancer – UV-induced p53 mutations in squamous-cell carcinoma
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., & Pontén, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10124 · Cited by 1,959
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Estimates of the worldwide incidence of eighteen major cancers in 1985
Parkin, D. M., Pisani, P., & Ferlay, J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540413 · Cited by 1,638
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,197
Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., & Vogelstein, B. (1990) · PubMed · Cited by 1,063
p53 mutations in colorectal cancer.
Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V., & Lane, D. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7555 · Cited by 1,003
Gaidano, G., Ballerini, P., Gong, J. Z., Inghirami, G., Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D. M., & Dalla-Favera, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5413 · Cited by 885
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
Scheffner, M., Münger, K., Byrne, J. C., & Howley, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5523 · Cited by 849
DeLeo, A. B., Jay, G., Appella, E., Dubois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721
Structural aspects of the p53 protein in relation to gene evolution.
Soussi, T., de Fromentel, C. C., & May, P. (1990) · PubMed · Cited by 603
Self-citationP53 expression in breast cancer
Cattoretti, G., Rilke, F., Andreola, S., D'Amato, L., & Delia, D. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410204 · Cited by 601
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Moll, U. M., Riou, G., & Levine, A. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7262 · Cited by 575
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Self-citationReifenberger, G., Liu, L., Ichimura, K., Schmidt, E., & Collins, V. P. (1993) · PubMed · Cited by 560
p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Leach, F. S., Tokino, T., Meltzer, P. S., Burrell, M., Oliner, J., Smith, S., HILL, D. E., Sidransky, D., Kinzler, K. W., & Vogelstein, B. (1993) · PubMed · Cited by 533
An immunochemical analysis of the human nuclear phosphoprotein p53
Vojtěšek, B., Bártek, J., Midgley, C. A., & Lane, D. P. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90122-a · Cited by 531
Chiba, I., Takahashi, T., Nau, M. M., D'Amico, D., Dt, C., Mitsudomi, T., Buchhagen, D. L., Carbone, D. P., Piantadosi, S., & KOGA, H. (1990) · PubMed · Cited by 514
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 474
Overexpression and mutation of p53 in epithelial ovarian cancer.
Marks, J. R., Davidoff, A. M., Kerns, B. J., Humphrey, P. A., Pence, J. C., Dodge, R. K., Clarke‐Pearson, D. L., Iglehart, J. D., Bast, R. C., & Berchuck, A. (1991) · PubMed · Cited by 464
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
Crawford, L. V., Pim, D. C., & Bulbrook, R. D. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910300404 · Cited by 450
p53 mutation in hepatocellular carcinoma after aflatoxin exposure
Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92236-u · Cited by 449
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.
Bressac, B., Galvin, K. M., Liang, T. J., Isselbacher, K. J., Wands, J. R., & Ozturk, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1973 · Cited by 416
Frequent mutation of the p53 gene in human esophageal cancer.
Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, R., & Harris, C. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9958 · Cited by 383
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami, Y., Hayashi, K., Hirohashi, S., & Sekiya, T. (1991) · PubMed · Cited by 374
p53 is mutated in a subset of advanced-stage prostate cancers.
Bookstein, R., MacGrogan, D., Hilsenbeck, S. G., Sharkey, F. E., & Allred, D. C. (1993) · PubMed · Cited by 362
Kress, M., May, E., Cassingena, R., & May, P. (1979) · Journal of Virology · doi:10.1128/jvi.31.2.472-483.1979 · Cited by 359
p53 expression and prognosis in gastric carcinoma
Martin, H. M., Filipe, M. I., Morris, R. W., Lane, D. P., & Silvestre, F. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500604 · Cited by 321
Crook, T., Wrede, D., Tidy, J. A., Vousden, K. H., Wrede, D., Tidy, J., Mason, W. P., & Evans, D. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90662-m · Cited by 309
Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation
Visakorpi, T., Kallioniemi, O.-P., Heikkinen, A., Koivula, T., & Isola, J. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.11.883 · Cited by 304
Genetic basis for p53 overexpression in human breast cancer.
Davidoff, A. M., Humphrey, P. A., Iglehart, J. D., & Marks, J. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.5006 · Cited by 285
Ahuja, H., Bar-Eli, M., Advani, S. H., Benchimol, S., & Cline, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6783 · Cited by 284
p53 Mutations in non-small cell lung cancer in Japan: Association between mutations and smoking
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90041-h · Cited by 275
Schlichtholz, B., Legros, Y., Gillet, D., Fruchart‐Gaillard, C., Marty, M. E., Lane, D. P., Calvo, F. M., & Soussi, T. (1992) · PubMed · Cited by 274
Self-citationp53 point mutation in HPV negative human cervical carcinoma cell lines.
Crook, T., Wrede, C. D., & Vousden, K. H. (1991) · PubMed · Cited by 272
Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.
Davidoff, A. M., Iglehart, J. D., & Marks, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3439 · Cited by 272
The Role of Papillomaviruses in Human Anogenital Cancer
zur Hausen, H., & Schneider, A. (1987) · The Papovaviridae · doi:10.1007/978-1-4757-0584-3_9 · Cited by 265
Stanbridge, E. J. (1990) · Annual Review of Genetics · doi:10.1146/annurev.ge.24.120190.003151 · Cited by 259
p53 gene mutations in Barrett's epithelium and esophageal cancer.
Casson, A. G., Mukhopadhyay, T., Cleary, K. R., Ro, J. Y., Levin, B., & Roth, J. A. (1991) · PubMed · Cited by 257
Porter, P. L., Gown, A. M., Kramp, S. G., & Coltrera, M. D. (1992) · PubMed · Cited by 255
p53 is frequently mutated in Burkitt's lymphoma cell lines
Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H., & Crook, T. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07837.x · Cited by 254
p53 gene mutation spectrum in hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 250
Screening patients for heterozygous p53 mutations using a functional assay in yeast
Ishioka, C., Frebourg, T., Yan, Y.-X., Vidal, M., Friend, S. H., Schmidt, S., & Iggo, R. (1993) · Nature Genetics · doi:10.1038/ng1093-124 · Cited by 243
p53 mutations in breast cancer.
Coles, C., Condie, A., Chetty, U., Steel, C., Evans, H. J., & Prosser, J. (1992) · PubMed · Cited by 241
Tamura, G., Kihana, T., Nomura, K., Terada, M., Sügimura, T., & Hirohashi, S. (1991) · PubMed · Cited by 228
Mutations in p53 as potential molecular markers for human breast cancer.
Runnebaum, I. B., Nagarajan, M., Bowman, M., Soto, D., & Sukumar, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10657 · Cited by 222
High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90526-4 · Cited by 207
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
(1991) · Lung Cancer · doi:10.1016/0169-5002(91)90309-t · Cited by 206
Kress, S., Sutter, C., Strickland, P. T., Mukhtar, H., Schweizer, J., & Schwarz, M. (1992) · PubMed · Cited by 196
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90119-5 · Cited by 196
Hollstein, M. C., Peri, L., Mandard, A. M., Welsh, J. A., Montesano, R., Metcalf, R. A., Bak, M., & Harris, C. C. (1991) · PubMed · Cited by 194
Fujita, M., Inoue, M., Tanizawa, O., Iwamoto, S., & Enomoto, T. (1992) · PubMed · doi:10.11501/3108031 · Cited by 193
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
Børresen, A. L., Hovig, E., Smith-Sørensen, B., Malkin, D., Lystad, S., Andersen, T. I., Nesland, J. M., Isselbacher, K. J., & Friend, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8405 · Cited by 190
Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.
Wp, B., Hollstein, M., He, A., Sm, Z., Resau, J., Bf, T., Ra, M., Ja, W., Midgley, C. A., & Lane, D. P. (1991) · PubMed · Cited by 183
Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90351-w · Cited by 178
P53 gene mutations in acute myeloid leukemia with 17p monosomy
Fenaux, P., Jonveaux, P., Quiquandon, I., Lai, J., Pignon, J., Loucheux-Lefebvre, M., Bauters, F., Berger, R., & Kerckaert, J. (1991) · Blood · doi:10.1182/blood.v78.7.1652.1652 · Cited by 175
p53 mutations in human lung tumors.
Cw, M., Simon, K., Aslo, A., Kok, K., Yokota, J., Buys, C. H. C. M., Terada, M., & Koeffler, H. P. (1992) · PubMed · Cited by 174
Lubin, R., Schlichtholz, B., Bengoufa, D., Zalcman, G., Trédaniel, J., Hirsch, A., de Fromentel, C. C., Preudhomme, C., Fenaux, P., Fournier, G., et al. (1993) · PubMed · Cited by 173
Self-citationRadioimmunoassay of the cellular protein p53 in mouse and human cell lines.
Benchimol, S., Pim, D. C., & Crawford, L. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01296.x · Cited by 170
Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50
Rotter, V, Witte, O. N., Coffman, R., & Baltimore, D. (1980) · Journal of Virology · doi:10.1128/jvi.36.2.547-555.1980 · Cited by 168
Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 164
Mutations in the p53 gene in primary human breast cancers.
Osborne, R. J., Merlo, G. R., Mitsudomi, T., Venesio, T., Liscia, D. S., Cappa, A. P. M., Chiba, I., Takahashi, T., Nau, M. M., & Callahan, R. (1991) · PubMed · Cited by 163
Melero, J., Stitt, D. T., Mangel, W. F., & Carroll, R. B. (1979) · Virology · doi:10.1016/0042-6822(79)90250-2 · Cited by 163
Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.
Spruck, C. H., Rideout, W. M., Olumi, A. F., Ohneseit, P. F., Yang, A. S., Tsai, Y. C., Nichols, P. W., Horn, T. D., Hermann, G. G., & Steven, K. E. (1993) · PubMed · Cited by 162
Scorsone, K. A., Zhou, Y. Z., Butel, J. S., & Slagle, B. L. (1992) · PubMed · Cited by 162
p53 mutations occur in aggressive breast cancer.
Mazars, R., Spinardi, L., BenCheikh, M., Simony-Lafontaine, J., Jeanteur, P., & Theillet, C. G. (1992) · PubMed · Cited by 156
Wagata, T., Shibagaki, I., Imamura, M., Shimada, Y., Toguchida, J., Yandell, D. W., Ikenaga, M., Tobe, T., & Ishizaki, K. (1993) · PubMed · Cited by 143
Chen, L., Neubauer, A., Kurisu, W., Waldman, F. M., Ljung, B., Goodson, W. H., Goldman, E. S., Moore, D. H., Balázs, M., & Liu, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3847 · Cited by 140
Schlichtholz, B., Trédaniel, J., Lubin, R., Zalcman, G., Hirsch, A., & Soussi, T. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.159 · Cited by 139
Self-citationAnalysis of the anti-p53 antibody response in cancer patients.
Labrecque, S., Naor, N., Thomson, D. M., & Matlashewski, G. (1993) · PubMed · Cited by 136
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology
Hall, P. A., Ray, A., Lemoine, N., Midgley, C. A., Krausz, T. N., & Lane, D. P. (1991) · The Lancet · doi:10.1016/0140-6736(91)90586-e · Cited by 132
Occurrence of p53 Gene Abnormalities in Gastric Carcinoma Tumors and Cells Lines
Kim, J., Takahashi, T., Chiba, I., Park, J.-G., Birrer, M. J., Roh, J. K., Lee, H. D., Kim, J.-P., Minna, J. D., & Gazdar, A. F. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.13.938 · Cited by 132
de Fromentel, C. C., Chandrasekaran, K., May, P., May-Levin, F., Mouriesse, H., & Lemerle, J. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390211 · Cited by 131
Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas
Pierceall, W. E., Mukhopadhyay, T., Goldberg, L. H., & Ananthaswamy, H. N. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040606 · Cited by 124
Mutations in the p53 gene in myelodysplastic syndromes.
Jonveaux, P., Fenaux, P., Quiquandon, I., Jm, P., Laı̈, J. L., Mh, L.-L., Goossens, M., Bauters, F., & Berger, R. (1991) · PubMed · Cited by 121
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
Thorlacius, S., Børresen‐Dale, A., & Eyfjörd, J. E. (1993) · PubMed · Cited by 119
Sameshima, Y., Matsuno, Y., Hirohashi, S., Shimosato, Y., Mizoguchi, H., Sugimura, T., Terada, M., & Yokota, J. (1992) · PubMed · Cited by 117
Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53‐mediated growth arrest.
Barak, Y., & Oren, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05270.x · Cited by 114
The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia, K. G., Gutiérrez, M. I., Huppi, K. E., Siwarski, D. F., & MAGRATH, I. T. (1992) · PubMed · Cited by 113
Base transitions are the most frequent genetic changes at P53 in gastric cancer.
Renault, B., van den Broek, M., Fodde, R., Wijnen, J., Pellegata, N. S., Amadori, D., Khan, P. M., & Ranzani, G. N. (1993) · PubMed · Cited by 105
Immunohistochemical study of p53 in human lung carcinomas.
Brambilla, E. M., Gazzéri, S., Moro‐Sibilot, D., de Fromentel, C. C., Gouyer, V., Jacrot, M., & Brambilla, C. (1993) · PubMed Central · Cited by 102
Genetic Suppression of Tumor Formation
Sager, R. (1985) · Advances in cancer research · doi:10.1016/s0065-230x(08)60025-1 · Cited by 101
P53 Gene Alterations in Human Prostate Carcinoma
Effert, P. J., McCoy, R. H., Walther, P. J., & Liu, E. T. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35458-7 · Cited by 101
p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from thailand
Hollstein, M. C., Wild, C. P., Bleicher, F., Chutimataewin, S., Harris, C. C., Srivatanakul, A., & Montesano, R. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530111 · Cited by 98
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma
Eccles, D., Brett, L., Lessells, A. M., Gruber, L., Lane, D. P., Steel, C., & Leonard, R. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.8 · Cited by 91
Pattern of p53 Gene Mutations in Breast Cancers of Women of the Midwestern United States
Sommer, S. S., Cunningham, J. M., McGovern, R. M., Saitoh, S., Schroeder, J. J., Wold, L. E., & Kovach, J. S. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.4.246 · Cited by 88
Hensel, C. H., Xiang, R. H., Sakaguchi, A. Y., & Naylor, S. L. (1991) · PubMed · Cited by 83
Buetow, K. H., Sheffield, V. C., Zhu, M., Zhou, T., Shen, F. M., Hino, O., Smith, M. A., McMahon, B. J., Lanier, A., & London, W. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9622 · Cited by 83
Hamelin, R., Jego, N., Laurent‐Puig, P., Vidaud, M., & Thomas, G. D. (1993) · PubMed · Cited by 70
Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors.
Chang, K., Ding, I., Kern, F. G., & Willingham, M. C. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.9.1680897 · Cited by 63
Duthu, A., Debuire, B., Romano, J., Ehrhart, J., Fiscella, M., May, E., Appella, E., & May, P. (1992) · PubMed · Cited by 57
Missense mutations and a deletion of the p53 gene in human gastric cancer
Matozaki, T., Sakamoto, C., Matsuda, K., Suzuki, T., Konda, Y., Nakano, O., Wada, K., Uchida, T., Nishisaki, H., Nagao, M., et al. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80133-0 · Cited by 56
Lohmann, D. R., Pütz, B., Reich, U., Böhm, J., Präuer, H. W., & Höfler, H. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)90601-7 · Cited by 53
P53 mutations in gastric carcinomas
Seruca, R., David, L., Holm, R., Nesland, J. M., Fangan, B. M., Castedo, S. M. M. J., Sobrinho-Simões, M. A., & Børresen, A.-L. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.149 · Cited by 53
Legros, Y., Lacabanne, V., D'Agay, M. F., Larsen, C., Pla, M., & Soussi, T. (1993) · PubMed · Cited by 33
Self-citationExpression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90516-z · Cited by 2
(1991) · PubMed
(1992) · PubMed
Cited by
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Angiostatin induces and sustains dormancy of human primary tumors in mice
O'Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,184
The S100 protein family: History, function, and expression
Zimmer, D. B., Cornwall, E. H., Landar, A., & Song, W. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00040-2 · Cited by 927
Citarda, F., Tomaselli, G., Capocaccia, R., Barcherini, S., Crespi, M., & Group, T. I. M. S. (2001) · Gut · doi:10.1136/gut.48.6.812 · Cited by 716
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation
Hollstein, M. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.141 · Cited by 499
Metadata
- Authors
- Soussi, T., Legros, Y., Lubin, R., Ory, K., & Schlichtholz, B.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1994-04
- Volume
- 57
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2010240655
- Cited by
- 353
- References
- 108
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.